Bipolar Disorder Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older
- People who have depression (either unipolar or bipolar) that has not responded well to standard treatments, but who did respond to a previous course of TMS (Transcranial Magnetic Stimulation) therapy — meaning their depression score improved by at least 50% during that earlier treatment
- People with a good enough command of French to complete questionnaires and follow instructions during brain scan (MRI) appointments and TMS treatment sessions
- People who are willing to follow all study procedures, attend for the full duration of the study, and keep study staff informed of any side effects or relevant health changes
- People who have given their written informed consent to take part in the study
- People who are enrolled in a social welfare or social security scheme (confirm with trial site)
Who may not be able to join:
- People who currently have certain additional psychiatric conditions, such as an active risk of suicide or an ongoing psychotic episode
- People with an unstable or uncontrolled physical health condition, such as active cancer, an uncontrolled hormonal (endocrinological) disorder, or untreated sleep apnea
- People for whom an MRI brain scan would not be safe — for example, those with certain metal implants in the body or severe claustrophobia
- People who are under a legal protection order (such as legal guardianship or conservatorship), or who are currently deprived of their liberty
- People who are pregnant or currently breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +332 99 33 39 37
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The sustainability of the antidepressant effect of a conventional 20 Hz rTMS course targeting the left left dorsolateral prefrontal cortex.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.